I would just say that we're actively engaged with partners on the biomanufacturing strategy. There are partnerships, such where Novavax has partnered with the biologics manufacturing facility in Montreal. That's one example and we'll continue to look for such opportunities.
On November 24th, 2022. See this statement in context.